Am J Perinatol 2024; 41(S 01): e486-e493
DOI: 10.1055/a-1905-5079
Original Article

Patient Perception of Care, Outcomes, and Consequences from Placenta Accreta Spectrum: A Survey-Based Study

1   Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, Massachusetts
2   Department of Obstetrics, Gynecology, and Reproductive Biology, Harvard Medical School, Boston, Massachusetts
,
Ronald M. Cornely
1   Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, Massachusetts
,
Rebecca Astake
1   Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, Massachusetts
,
Michele R. Hacker
1   Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, Massachusetts
2   Department of Obstetrics, Gynecology, and Reproductive Biology, Harvard Medical School, Boston, Massachusetts
› Author Affiliations
Funding This work was funded, in part, by unrestricted funding from Gary and Elizabeth Lowe, The Carney Family Charitable Foundation, and the Charles Koch Foundation.
This work was conducted with support from Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health Award UL: 1TR002541) and financial contributions from Harvard University and its affiliated academic health care centers.

Abstract

Objective Placenta accreta spectrum (PAS) is an obstetric diagnosis that carries significant risks. However, little is known about patient perceptions of care. This study was conducted to describe the patient experience, reported outcomes, and assess geographical variation in PAS care in the United States.

Study Design Partnering with a PAS patient advocacy organization, we conducted an online survey of PAS patients. Perceptions of care and outcomes, and geographic variation were described.

Results We received 108 responses (69% response rate); 103 respondents delivered in the United States. Demographic characteristics were similar across each region. Most (67%) reported at least one prior cesarean delivery and 53% reported placenta previa in the PAS pregnancy. Over half (63%) reported an antenatal suspicion of PAS and 66% of those respondents reported changing their delivery hospital as a result of their antenatal diagnosis. Though not statistically significant, both showed variability across regions (both p ≥0.60). Seventy-five percent of respondents with antenatal diagnosis reported their pregnancy was managed by a dedicated PAS care team, which did not differ by region (p = 0.80). A majority of respondents (75%) felt their PAS care team was prepared for their delivery; this too did not vary across regions (p = 0.97). Many respondents reported at least one physical (63%) or mental health (17%) adverse outcome as a result of their PAS pregnancy.

Conclusion As reported by prior PAS patients, perception of care and outcomes are overall favorable. There are long-term physical and mental adverse consequences reported. Geographical variation is mixed, however, national guidelines are predominately followed.

Key Points

  • Patient perceptions of care and outcomes are overall positive and favorable.

  • Long lasting physical and mental health consequence from PAS pregnancies are commonly seen.

  • Multidisciplinary care is widely adopted for PAS pregnancies.

Supplementary Material



Publication History

Received: 11 February 2022

Accepted: 12 July 2022

Accepted Manuscript online:
20 July 2022

Article published online:
29 September 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 American College of Obstetricians and Gynecologists; Society for Maternal-Fetal Medicine. Obstetric care consensus no. 7: placenta accreta spectrum. Obstet Gynecol 2018; 132 (06) e259-e275
  • 2 Grobman WA, Gersnoviez R, Landon MB. et al; National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network. Pregnancy outcomes for women with placenta previa in relation to the number of prior cesarean deliveries. Obstet Gynecol 2007; 110 (06) 1249-1255
  • 3 Bailit JL, Grobman WA, Rice MM. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network. Morbidly adherent placenta treatments and outcomes. Obstet Gynecol 2015; 125 (03) 683-689
  • 4 Zaat TR, van Steijn ME, de Haan-Jebbink JM, Olff M, Stramrood CAI, van Pampus MG. Posttraumatic stress disorder related to postpartum haemorrhage: a systematic review. Eur J Obstet Gynecol Reprod Biol 2018; 225: 214-220
  • 5 Sentilhes L, Gromez A, Clavier E, Resch B, Descamps P, Marpeau L. Long-term psychological impact of severe postpartum hemorrhage. Acta Obstet Gynecol Scand 2011; 90 (06) 615-620
  • 6 Grover B, Einerson BD, Keenan KD. et al. Patient-reported health outcomes and quality of life after peripartum hysterectomy for placenta accreta spectrum. Am J Perinatol 2022; 39 (03) 281-287
  • 7 Tol ID, Yousif M, Collins SL. Posttraumatic stress disorder (PTSD): The psychological sequelae of abnormally invasive placenta (AIP). Placenta 2019; 81: 42-45
  • 8 Bartels HC, Terlizzi K, Cooney N. et al. Quality of life and sexual function after a pregnancy complicated by placenta accreta spectrum. Aust N Z J Obstet Gynaecol 2021; 61 (05) 708-714
  • 9 Shainker SA, Coleman B, Timor-Tritsch IE. et al; Society for Maternal-Fetal Medicine. Electronic address: pubs@smfm.org. Special report of the society for maternal-fetal medicine placenta accreta spectrum ultrasound marker task force: consensus on definition of markers and approach to the ultrasound examination in pregnancies at risk for placenta accreta spectrum. Am J Obstet Gynecol 2021; 224 (01) B2-B14
  • 10 Hecht JL, Baergen R, Ernst LM. et al. Classification and reporting guidelines for the pathology diagnosis of placenta accreta spectrum (PAS) disorders: recommendations from an expert panel. Mod Pathol 2020; 33 (12) 2382-2396
  • 11 Collins SL, Alemdar B, van Beekhuizen HJ. et al; International Society for Abnormally Invasive Placenta (IS-AIP). Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the International Society for Abnormally Invasive Placenta. Am J Obstet Gynecol 2019; 220 (06) 511-526
  • 12 Jauniaux E, Bhide A, Kennedy A, Woodward P, Hubinont C, Collins S. FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: prenatal diagnosis and screening. Int J Gynaecol Obstet 2018; 140 (03) 274-280
  • 13 Jauniaux E, Collins S, Burton GJ. Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging. Am J Obstet Gynecol 2018; 218 (01) 75-87
  • 14 Sargent W, Collins SL. Are women antenatally diagnosed with abnormally invasive placenta receiving optimal management in England? An observational study of planned place of delivery. Acta Obstet Gynecol Scand 2019; 98 (03) 337-341
  • 15 Esakoff TF, Handler SJ, Granados JM, Caughey AB. PAMUS: placenta accreta management across the United States. J Matern Fetal Neonatal Med 2012; 25 (06) 761-765
  • 16 Einerson BD, Watt MH, Sartori B, Silver R, Rothwell E. Lived experiences of patients with placenta accreta spectrum in Utah: a qualitative study of semi-structured interviews. BMJ Open 2021; 11 (11) e052766
  • 17 Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42 (02) 377-381
  • 18 2010 census regions and divisions of the united states. Accessed January 12, 2021 at: https://www.census.gov/geographies/reference-maps/2010/geo/2010-census-regions-and-divisions-of-the-united-states.html
  • 19 Robinson BK, Grobman WA. Effectiveness of timing strategies for delivery of individuals with placenta previa and accreta. Obstet Gynecol 2010; 116 (04) 835-842
  • 20 Shamshirsaz AA, Fox KA, Salmanian B. et al. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach. Am J Obstet Gynecol 2015; 212 (02) 218.e1-218.e9
  • 21 Shamshirsaz AA, Fox KA, Erfani H. et al. Multidisciplinary team learning in the management of the morbidly adherent placenta: outcome improvements over time. Am J Obstet Gynecol 2017; 216 (06) 612.e1-612.e5
  • 22 Wright JD, Silver RM, Bonanno C. et al. Practice patterns and knowledge of obstetricians and gynecologists regarding placenta accreta. J Matern Fetal Neonatal Med 2013; 26 (16) 1602-1609
  • 23 Silver RM, Landon MB, Rouse DJ. et al; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol 2006; 107 (06) 1226-1232
  • 24 Logue TC, Wen T, Monk C. et al. Trends in and complications associated with mental health condition diagnoses during delivery hospitalizations. Am J Obstet Gynecol 2022; 226 (03) 405.e1-405.e16